Total Payments
$617.28
2024 Payments
$219.31
Companies
10
Transactions
22
Medicare Patients
2,749
Medicare Billing
$284,617
Payment Breakdown by Category
Food & Beverage$389.88 (63.2%)
Education$227.40 (36.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $389.88 | 18 | 63.2% |
| Education | $227.40 | 4 | 36.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $265.52 | 6 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $93.66 | 6 | $0 (2024) |
| Taiho Oncology, Inc. | $77.63 | 1 | $0 (2018) |
| Sirtex Medical Inc | $46.56 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $45.09 | 2 | $0 (2024) |
| EMD Serono, Inc. | $20.56 | 1 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.08 | 1 | $0 (2023) |
| GENZYME CORPORATION | $18.79 | 1 | $0 (2024) |
| Medtronic USA, Inc. | $18.47 | 1 | $0 (2019) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $219.31 | 7 | Janssen Biotech, Inc. ($99.99) |
| 2023 | $160.48 | 4 | Janssen Biotech, Inc. ($99.95) |
| 2022 | $48.05 | 3 | E.R. Squibb & Sons, L.L.C. ($27.49) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2019 | $99.89 | 6 | Janssen Biotech, Inc. ($65.58) |
| 2018 | $77.63 | 1 | Taiho Oncology, Inc. ($77.63) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $25.90 | General |
| Category: Interventional Oncology | ||||||
| 08/29/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Oncology | ||||||
| 07/23/2024 | E.R. Squibb & Sons, L.L.C. | — | Education | In-kind items and services | $15.54 | General |
| 07/01/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Oncology | ||||||
| 05/10/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $14.00 | General |
| Category: Oncology | ||||||
| 03/21/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Oncology | ||||||
| 09/27/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2023 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $20.66 | General |
| Category: Interventional Oncology | ||||||
| 03/21/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 03/01/2023 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $20.79 | General |
| Category: Oncology | ||||||
| 09/28/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $20.56 | General |
| 09/21/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $14.66 | General |
| 02/10/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $12.83 | General |
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 10/22/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Oncology | ||||||
| 09/17/2019 | Medtronic USA, Inc. | KYPHON Balloon Kyphoplasty (Device) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 08/06/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: Oncology | ||||||
| 07/10/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Oncology | ||||||
| 05/14/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Oncology | ||||||
| 01/28/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Oncology | ||||||
| 03/23/2018 | Taiho Oncology, Inc. | Lonsurf (Drug) | Food and Beverage | In-kind items and services | $77.63 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 625 | 855 | $286,367 | $56,705 |
| 2022 | 5 | 775 | 912 | $329,133 | $68,571 |
| 2021 | 5 | 658 | 1,029 | $354,299 | $77,657 |
| 2020 | 6 | 691 | 1,218 | $429,243 | $81,684 |
Total Patients
2,749
Total Services
4,014
Medicare Billing
$284,617
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 233 | 391 | $148,998 | $28,656 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 208 | 262 | $70,549 | $13,281 | 18.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $30,558 | $6,606 | 21.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 38 | $20,136 | $4,106 | 20.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $14,254 | $3,405 | 23.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 51 | 65 | $1,432 | $494.65 | 34.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 14 | 15 | $440.70 | $155.25 | 35.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 212 | 264 | $97,650 | $18,980 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 163 | 208 | $79,263 | $17,693 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 127 | 140 | $37,698 | $7,800 | 20.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 143 | 170 | $42,946 | $7,761 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 45 | 45 | $23,306 | $4,575 | 19.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 27 | 27 | $17,450 | $4,334 | 24.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 34 | 34 | $16,673 | $3,859 | 23.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $7,790 | $2,038 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 12 | $6,359 | $1,530 | 24.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 299 | 577 | $206,566 | $45,648 | 22.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 235 | 327 | $79,788 | $17,712 | 22.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 86 | 86 | $46,612 | $9,590 | 20.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 25 | 26 | $12,480 | $2,930 | 23.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $8,853 | $1,776 | 20.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 425 | 928 | $315,889 | $58,477 | 18.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 73 | 73 | $37,522 | $7,368 | 19.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 51 | 62 | $28,974 | $5,928 | 20.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 35 | 35 | $21,822 | $4,812 | 22.1% |
About Dr. Joseph Pennacchio, MD
Dr. Joseph Pennacchio, MD is a Hematology & Oncology healthcare provider based in Stoneham, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053387795.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Pennacchio, MD has received a total of $617.28 in payments from pharmaceutical and medical device companies, with $219.31 received in 2024. These payments were reported across 22 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($389.88).
As a Medicare-enrolled provider, Pennacchio has provided services to 2,749 Medicare beneficiaries, totaling 4,014 services with total Medicare billing of $284,617. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Stoneham, MA
- Active Since 02/23/2006
- Last Updated 01/30/2013
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1053387795
Products in Payments
- RYBREVANT (Drug) $99.99
- ERLEADA (Drug) $99.95
- Lonsurf (Drug) $77.63
- Erleada (Drug) $65.58
- SIR-Spheres Microspheres (Device) $46.56
- Xtandi (Drug) $45.09
- OPDUALAG (Drug) $34.79
- GILOTRIF (Drug) $19.08
- SARCLISA (Biological) $18.79
- KYPHON Balloon Kyphoplasty (Device) $18.47
- OPDIVO (Biological) $15.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.